Skip to content
Open access

Tumor Characteristics and Event Free Survival in Older and Younger Women with Early Breast Cancer

Aug 2026 · Current Oncology · 0 citations · 54 references

TL;DR

In a sample of women with Stage I-III breast cancer who received chemotherapy with curative intent, triple negative subtype, smoking history, tumor size, and surgery type were significantly associated with shorter five-year event free survival.

Abstract

Background: Age, race, body mass index (BMI), breast density, parity, smoking and alcohol use are associated with increased risk for breast cancer. These factors, as well as tumor characteristics, treatment regimens and comorbidities, are analyzed for associations with five-year event free survival (EFS) in a sample of women with Stage I-III breast cancer who received chemotherapy with curative intent. Methods: EFS was defined in terms of breast cancer recurrence, second primary, metastasis, and overall survival. Analyses were stratified by age (under age 65 vs. over age 65). EFS was estimated using the Kaplan–Meier method and compared using a Cox proportional hazard model. Results: In a sample of 821 women, mean age at diagnosis was 54 years, with 75% White and 22% Black. Younger women had higher proportions of Stage II and III tumors (p = 0.005), larger tumor size (p = 0.0004), and higher breast density (p = 0.003). Five-year EFS was 91% among younger vs. 82% among older women (p = 0.0005). In women aged < 65, there were 48 EFS events, and triple negative patients had significantly worse EFS compared to other subtypes (p = 0.003). Smokers also had worse EFS (p = 0.04). In women aged ≥ 65, there were 26 events, and both tumor size (p = 0.02) and mastectomy (p = 0.03) were significant for EFS. Conclusions: In our sample, triple negative subtype, smoking history, tumor size, and surgery type were significantly associated with shorter EFS. Race, BMI, alcohol use, parity, breast density, radiation treatment, and specific chemotherapy regimen were not significant for EFS in either age group.

Read PDF

Similar papers

Open access Aug 2026

Time-dependent prognostic impact of tumor grade in stage I-III breast cancers

Background Breast cancer (BC) mortality risk extends over decades; yet, the temporal prognostic patterns of histological grade across subtypes and stages remain unclear. Patients and methods Women with stage I-III BC diagnosed between 2000 and 2018 were identified from Surveillance, Epidemiology, and End Results regist...

M. Mariani, M. Ochocki, G. Bianchini et al. · 0 citations
Aug 2026

The association between body mass index and non-metastatic breast cancer disease free survival (DFS) and distant metastasis free survival (DMFS) in hormone receptor positive postmenopausal women treated with aromatase inhibitors

Obesity is a major health concern; research has linked obesity to increased breast cancer risk and poor survival outcome in postmenopausal women with hormone receptor–positive disease. Suggesting that adiposity may reduce the therapeutic efficacy of endocrine therapies, leading to higher risks of recurrence....

Noha Eslam Attia Sakr, H. Abdulla, Ahmed Gaballa et al. · 0 citations
Open access Sep 2026

Breast Cancer Method of Detection: Screening Associated with Favorable Tumor Characteristics, Treatment, and Survival Across Age Groups.

OBJECTIVE Breast cancer method of detection (MOD) describes how a cancer is first identified: through screening or non-screening (symptomatic/incidental) presentation. We examined associations between MOD and patient demographics, tumor characteristics, treatment patterns, and survival. METHODS This retrospective coh...

Babita Panigrahi, Alexandra DiTommaso, N. Ghuman et al. · 0 citations
Open access Aug 2026

Ten-year survival of women with invasive breast cancer by stage, molecular subtype, and grade combined: a population-based study

Abstract Background Stage at diagnosis, histologic grade, and molecular subtypes are established prognostic indicators for women with breast cancer (BC), but their impact on population-based survival estimates is poorly documented. This study assessed long-term BC survival trends according to these factors. Methods We...

Fabiola Giudici, D. Serraino, F. Puglisi et al. · 0 citations
Open access Sep 2026

Mapping significant clinical factors to relapse-free survival prognosis in breast cancer patients

The results show that patients who received chemotherapy demonstrated a shorter median RFS compared to those who did not, and radiotherapy was associated with improved prognosis, in line with meta-analyses showing reduced breast cancer mortality post-radiotherapy.

Boby Al Qurthuby, I. M. Murwantara · 0 citations
Open access Jul 2026

Age-related survival gaps in triple-negative breast cancer: a 10-year real-world analysis

The poorer prognosis in older adults with TNBC is significantly associated with clinical management disparities and low SOC adherence, while histopathological markers of tumor aggressiveness remain highly prevalent across the age spectrum.

Dinis Galhardo, B. Peleteiro, Fernando Osório · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.